DENTSPLY SIRONA (NASDAQ:XRAY) Shares Down 5.8%

→ Elon to Transform U.S. Economy? (From Porter & Company) (Ad)

DENTSPLY SIRONA Inc. (NASDAQ:XRAY - Get Free Report) was down 5.8% during mid-day trading on Thursday . The stock traded as low as $28.40 and last traded at $28.44. Approximately 4,633,287 shares traded hands during trading, an increase of 41% from the average daily volume of 3,297,372 shares. The stock had previously closed at $30.18.

Analyst Upgrades and Downgrades

Several analysts have commented on the stock. Piper Sandler raised their price objective on shares of DENTSPLY SIRONA from $31.00 to $35.00 and gave the stock a "neutral" rating in a report on Friday, January 12th. SVB Leerink began coverage on DENTSPLY SIRONA in a research note on Monday, February 26th. They issued an "outperform" rating and a $42.00 price target on the stock. Needham & Company LLC reiterated a "buy" rating and issued a $42.00 price objective on shares of DENTSPLY SIRONA in a report on Thursday, February 29th. StockNews.com upgraded shares of DENTSPLY SIRONA from a "hold" rating to a "buy" rating in a report on Friday, January 19th. Finally, Leerink Partnrs reaffirmed an "outperform" rating on shares of DENTSPLY SIRONA in a research report on Monday, February 26th. Three analysts have rated the stock with a hold rating and seven have issued a buy rating to the stock. Based on data from MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and a consensus target price of $39.50.


Check Out Our Latest Analysis on XRAY

DENTSPLY SIRONA Trading Down 6.0 %

The stock has a market cap of $5.88 billion, a PE ratio of -46.60, a price-to-earnings-growth ratio of 1.21 and a beta of 1.00. The firm has a 50-day moving average price of $32.34 and a 200-day moving average price of $32.76. The company has a debt-to-equity ratio of 0.55, a quick ratio of 0.95 and a current ratio of 1.38.

DENTSPLY SIRONA (NASDAQ:XRAY - Get Free Report) last issued its earnings results on Thursday, May 2nd. The medical instruments supplier reported $0.42 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.42. The business had revenue of $953.00 million during the quarter, compared to analysts' expectations of $969.45 million. DENTSPLY SIRONA had a negative net margin of 3.33% and a positive return on equity of 11.14%. The business's revenue for the quarter was down 2.6% compared to the same quarter last year. During the same period in the previous year, the company earned $0.39 earnings per share. As a group, equities analysts anticipate that DENTSPLY SIRONA Inc. will post 2.05 EPS for the current fiscal year.

DENTSPLY SIRONA Increases Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Friday, April 12th. Investors of record on Friday, March 29th were given a $0.16 dividend. The ex-dividend date of this dividend was Wednesday, March 27th. This is a boost from DENTSPLY SIRONA's previous quarterly dividend of $0.14. This represents a $0.64 annualized dividend and a yield of 2.26%. DENTSPLY SIRONA's dividend payout ratio is -103.22%.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently modified their holdings of XRAY. Norges Bank bought a new position in DENTSPLY SIRONA during the fourth quarter valued at approximately $114,207,000. Nuance Investments LLC raised its stake in DENTSPLY SIRONA by 30.4% during the 4th quarter. Nuance Investments LLC now owns 11,603,889 shares of the medical instruments supplier's stock valued at $412,982,000 after buying an additional 2,702,457 shares during the last quarter. Generation Investment Management LLP lifted its holdings in shares of DENTSPLY SIRONA by 43.4% during the 4th quarter. Generation Investment Management LLP now owns 6,598,211 shares of the medical instruments supplier's stock valued at $234,830,000 after buying an additional 1,998,012 shares during the period. Wellington Management Group LLP boosted its stake in shares of DENTSPLY SIRONA by 21.1% in the 4th quarter. Wellington Management Group LLP now owns 8,138,253 shares of the medical instruments supplier's stock worth $289,640,000 after buying an additional 1,419,503 shares during the last quarter. Finally, Cooke & Bieler LP boosted its stake in shares of DENTSPLY SIRONA by 18.3% in the 4th quarter. Cooke & Bieler LP now owns 7,061,910 shares of the medical instruments supplier's stock worth $251,333,000 after buying an additional 1,092,922 shares during the last quarter. 95.70% of the stock is owned by institutional investors.

About DENTSPLY SIRONA

(Get Free Report)

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.

See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

→ 4 Cryptos BETTER than Bitcoin (From True Market Insiders) (Ad)

Should you invest $1,000 in DENTSPLY SIRONA right now?

Before you consider DENTSPLY SIRONA, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and DENTSPLY SIRONA wasn't on the list.

While DENTSPLY SIRONA currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Elon Musk's Next Move Cover

Wondering when you'll finally be able to invest in SpaceX, StarLink, or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.

Get This Free Report

Featured Articles and Offers

4 Downgraded Stocks Still Worth a Look

4 Downgraded Stocks Still Worth a Look

Despite recent analyst downgrades, these stocks might offer golden opportunities to buy on a dip.

Search Headlines: